Vertaling van "board and medicines " (Nederlands → Frans) :

Malaria kills a child under age five every 30 seconds in Africa Only 10% of R&D funds are used for research into 90% of the world’s health problems The NITD was granted USD 20 million in 2006 by the Wellcome Trust, the Singapore Economic Development Board and Medicines for Malaria Venture to initiate joint research on malaria Leprosy has dropped by over 90% since 1985 Deliveries for Coartem have climbed from four million treatments in 2004 to over 60 million in 2006
En Afrique, la malaria tue un enfant de moins de cinq ans toutes les 30 secondes Seuls 10% des fonds consacrés à la recherche sont investis dans les maladies qui représentent 90% des problèmes de santé dans le monde En 2006, l’Institut Novartis pour les maladies tropicales a obtenu du Wellcome Trust, du Singapore Economic Development Board et de Medicines for Malaria Venture USD 20 millions pour initier un programme commun de recherche sur la malaria Depuis 1985, la lèpre a diminué de plus de 90% Entre 2004 et 2006, les livraisons de Coartem sont passées de 4 millions à plus de 60 millions de traitements

Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products
Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products

Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)
Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)

National representation A number of FAMHP employees represent the Minister of Public Health on a number of commissions and consultation platforms, such as the commission for the reimbursement of medicines (CTG - CRM) and the technical pharmaceutical board (TFR - CTP) of the RIZIV - INAMI, the price commission for pharmaceutical proprietary products of the FPS Economy, and of the FANC.
National representation A number of FAMHP employees represent the Minister of Public Health on a number of commissions and consultation platforms, such as the commission for the reimbursement of medicines (CTG - CRM) and the technical pharmaceutical board (TFR - CTP) of the RIZIV - INAMI, the price commission for pharmaceutical proprietary products of the FPS Economy, and of the FANC.

Loopbaan: Mevrouw Cooke heeft een aantal functies bekleed in de Ierse farmaceutische industrie voordat zij als farmaceutisch adviseur in dienst kwam van de Ierse Medicines Board.
Expérience professionnelle: Mme Cooke a occupé divers postes au sein de l’industrie pharmaceutique avant de rejoindre l’Irish Medicines Board en tant qu’évaluateur pour les produits pharmaceutiques en 1988.